Sinco Pharma Releases Updated Board Composition and Committee Structure

Bulletin Express04-30

Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) disclosed the latest composition of its Board of Directors and Board committees on 30 April 2026.

Board Composition • Executive Directors: Mr. Huang Zhijian (Vice Chairman) and Mr. Lei Shifeng • Non-executive Director: Ms. Jing Huan • Independent Non-executive Directors: Mr. Bai Zhizhong (Lead INED), Mr. Lau Ying Kit, Mr. Wang Qing and Mr. Liu Wenfang

Committee Leadership and Membership • Audit Committee: Chaired by Mr. Lau Ying Kit, with Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members. • Remuneration Committee: Chaired by Mr. Wang Qing, with Mr. Lei Shifeng, Mr. Liu Wenfang and Mr. Bai Zhizhong as members. • Nomination Committee: Chaired by Ms. Jing Huan, with Mr. Lau Ying Kit, Mr. Liu Wenfang and Mr. Bai Zhizhong as members. • Internal Control and Corporate Governance Committee: Chaired by Mr. Lau Ying Kit, with Mr. Lei Shifeng, Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.

Notably, Mr. Huang Zhijian, while serving as Vice Chairman and Executive Director, does not hold positions on any of the four committees. Independent Non-executive Directors take prominent roles across all committees, underscoring the company’s emphasis on governance oversight.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181489362?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181489362","market":"us","top_or_hot":-1,"title":"Sinco Pharma Releases Updated Board Composition and Committee Structure","media":"Bulletin Express","content":"<p>Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) disclosed the latest composition of its Board of Directors and Board committees on 30 April 2026.</p>\n<p>Board Composition  \n• Executive Directors: Mr. Huang Zhijian (Vice Chairman) and Mr. Lei Shifeng  \n• Non-executive Director: Ms. Jing Huan  \n• Independent Non-executive Directors: Mr. Bai Zhizhong (Lead INED), Mr. Lau Ying Kit, Mr. Wang Qing and Mr. Liu Wenfang</p>\n<p>Committee Leadership and Membership  \n• Audit Committee: Chaired by Mr. Lau Ying Kit, with Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Remuneration Committee: Chaired by Mr. Wang Qing, with Mr. Lei Shifeng, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Nomination Committee: Chaired by Ms. Jing Huan, with Mr. Lau Ying Kit, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Internal Control and Corporate Governance Committee: Chaired by Mr. Lau Ying Kit, with Mr. Lei Shifeng, Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.</p>\n<p>Notably, Mr. Huang Zhijian, while serving as Vice Chairman and Executive Director, does not hold positions on any of the four committees. Independent Non-executive Directors take prominent roles across all committees, underscoring the company’s emphasis on governance oversight.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinco Pharma Releases Updated Board Composition and Committee Structure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinco Pharma Releases Updated Board Composition and Committee Structure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-30 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) disclosed the latest composition of its Board of Directors and Board committees on 30 April 2026.</p>\n<p>Board Composition  \n• Executive Directors: Mr. Huang Zhijian (Vice Chairman) and Mr. Lei Shifeng  \n• Non-executive Director: Ms. Jing Huan  \n• Independent Non-executive Directors: Mr. Bai Zhizhong (Lead INED), Mr. Lau Ying Kit, Mr. Wang Qing and Mr. Liu Wenfang</p>\n<p>Committee Leadership and Membership  \n• Audit Committee: Chaired by Mr. Lau Ying Kit, with Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Remuneration Committee: Chaired by Mr. Wang Qing, with Mr. Lei Shifeng, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Nomination Committee: Chaired by Ms. Jing Huan, with Mr. Lau Ying Kit, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Internal Control and Corporate Governance Committee: Chaired by Mr. Lau Ying Kit, with Mr. Lei Shifeng, Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.</p>\n<p>Notably, Mr. Huang Zhijian, while serving as Vice Chairman and Executive Director, does not hold positions on any of the four committees. Independent Non-executive Directors take prominent roles across all committees, underscoring the company’s emphasis on governance oversight.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06833","symbol_name":"兴科蓉医药","start_time":0,"source_url":"","article_id":"1181489362","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181489362","pubTimestamp":1777550730,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) disclosed the latest composition of its Board of Directors and Board committees on 30 April 2026. Board Composition   • Executive Directors: Mr....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06833":"兴科蓉医药"},"translate_title":"Sinco Pharma发布最新的董事会组成和委员会结构","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06833":1},"content_text":"Sinco Pharmaceuticals Holdings Limited (Sinco Pharma) disclosed the latest composition of its Board of Directors and Board committees on 30 April 2026.\nBoard Composition  \n• Executive Directors: Mr. Huang Zhijian (Vice Chairman) and Mr. Lei Shifeng  \n• Non-executive Director: Ms. Jing Huan  \n• Independent Non-executive Directors: Mr. Bai Zhizhong (Lead INED), Mr. Lau Ying Kit, Mr. Wang Qing and Mr. Liu Wenfang\nCommittee Leadership and Membership  \n• Audit Committee: Chaired by Mr. Lau Ying Kit, with Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Remuneration Committee: Chaired by Mr. Wang Qing, with Mr. Lei Shifeng, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Nomination Committee: Chaired by Ms. Jing Huan, with Mr. Lau Ying Kit, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.  \n• Internal Control and Corporate Governance Committee: Chaired by Mr. Lau Ying Kit, with Mr. Lei Shifeng, Mr. Wang Qing, Mr. Liu Wenfang and Mr. Bai Zhizhong as members.\nNotably, Mr. Huang Zhijian, while serving as Vice Chairman and Executive Director, does not hold positions on any of the four committees. Independent Non-executive Directors take prominent roles across all committees, underscoring the company’s emphasis on governance oversight.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181489362","isCrawlerRequest":true}